Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, today announced that it has raised an additional $25 mil Cedilla Therapeutics Completes $82.6M Series ...

Cedilla Therapeutics launched Tuesday with a $56 million investment from Third Rock and a mission to develop small molecules that target the stability of cancer-driving proteins. Others have ...

Cedilla is also eligible to receive tiered royalty payments from Bayer on medicines based on the former’s technology commercialized by Bayer. In the year so far, shares of BAYRY have gained 8.7% ...

The Cedilla pipeline lists the program between preclinical and IND. The upshot is Bayer has ceded a head start to its rivals for the CDK2 market. Pfizer is set to present phase 1/2a data on its ...